Search
for
Sort by
Research 151–180 of 1000+
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- The role of lymphocytes in the development and treatment of alopecia areata
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Mammalian Fetal Organ Regeneration
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Racial and Gender Influences on Skin Disease
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- New Drugs: Dutasteride
- Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase
- Finasteride as a potential tool to improve Mesenchymal stem cell transplantation for myocardial infarction
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Abstract 1219: Defective catagen entry in EGFR deficient skin precedes cutaneous inflammation
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes